Litcius/Paper detail

Role of the mucin-like glycoprotein FCGBP in mucosal immunity and cancer

Qiao Liu, Xia Niu, Yang Li, Jiarui Zhang, Shaojun Zhu, Qi-yuan Yang, Wei Zhang, Gong Li

2022Frontiers in Immunology69 citationsDOIOpen Access PDF

Abstract

IgGFc-binding protein (FCGBP) is a mucin first detected in the intestinal epithelium. It plays an important role in innate mucosal epithelial defense, tumor metastasis, and tumor immunity. FCGBP forms disulfide-linked heterodimers with mucin-2 and members of the trefoil factor family. These formed complexes inhibit bacterial attachment to mucosal surfaces, affect the motility of pathogens, and support their clearance. Altered FCGBP expression levels may be important in the pathologic processes of Crohn's disease and ulcerative colitis. FCGBP is also involved in regulating the infiltration of immune cells into tumor microenvironments. Thus, the molecule is a valuable marker of tumor prognosis. This review summarizes the functional relevance and role of FCGBP in immune responses and disease development, and highlights the potential role in diagnosis and predicting tumor prognosis.

Topics & Concepts

MucinImmune systemInnate immune systemMUC1ImmunologyGlycoproteinBiologyImmunityColorectal cancerMotilityMetastasisDiseaseCancer researchCancerMedicinePathologyCell biologyMolecular biologyGeneticsGalectins and Cancer BiologyGlycosylation and Glycoproteins ResearchEscherichia coli research studies
Role of the mucin-like glycoprotein FCGBP in mucosal immunity and cancer | Litcius